Tirzepatide represents a groundbreaking therapeutic agent for individuals struggling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://majaqqtz513759.blogstival.com/62120220/tirzepatide-a-novel-glp-1-and-gip-receptor-agonist